- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (2)
4 result(s) found for: Purified water.
Displaying page 1 of 1.
EudraCT Number: 2009-015642-35 | Sponsor Protocol Number: POVO-2009 | Start Date*: Information not available in EudraCT |
Sponsor Name:medphano Arzneimittel GmbH | ||
Full Title: Doppelblinde, randomisierte, kontrollierte, klinisch-experimentelle Studie der Phase II zum Nachweis der Wirksamkeit mittels Vasokonstriktionstest von Polcortolon® N Spray gegenüber Volonimat® Salb... | ||
Medical condition: healthy volunteers. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001725-75 | Sponsor Protocol Number: 2015-DFU-301 | Start Date*: 2018-12-12 |
Sponsor Name:FirstString Research, Inc. | ||
Full Title: A Phase 3, Randomized, Double-blind, Parallel-group, Vehicle controlled, Multicenter Study of the Efficacy and Safety of Granexin Gel in the Treatment of Diabetic Foot Ulcer (GAIT 1) | ||
Medical condition: Diabetic Foot Ulcer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2008-005890-37 | Sponsor Protocol Number: K201-I/280301BS | Start Date*: 2008-12-30 | |||||||||||
Sponsor Name:Moberg Derma AB | |||||||||||||
Full Title: Assessment of the effects on barrier impairment, clinical features and bacterial colonization of topical formulations in patients with atopic eczema; a phase IIa, single-center, randomized, observe... | |||||||||||||
Medical condition: To assess the barrier impairment, clinical skin condition and bacterial colonization in patients with atopic eczema | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-003277-15 | Sponsor Protocol Number: 8400-211 | Start Date*: 2016-09-02 | |||||||||||
Sponsor Name:Idera Pharmaceuticals, Inc. | |||||||||||||
Full Title: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Trial of IMO-8400 in Patients with Dermatomyositis | |||||||||||||
Medical condition: Dermatomyositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) HU (Completed) SE (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
